13 March 2024
Nexteq plc
("Nexteq" or the "Group")
Director/PDMR Share Transfers
Nexteq (AIM: NXQ), a leading technology solutions provider to customers in selected industrial markets, has been informed of the transfer of a total of, in aggregate, 70,000 ordinary shares of 0.1p each in Nexteq plc ("Ordinary Shares") by Nick Jarmany, Non-Executive Deputy Chair of the Group.
The share transfer is to six individuals by way of a gift to certain individuals and hence for nil consideration in each case. The individuals are not persons closely associated with Mr Jarmany, as defined by the Market Abuse Regulation.
Following the transfer, Nick Jarmany and persons closely associated with him are subsequently interested in a total of 11,131,163 Ordinary Shares representing 16.74 per cent of the Group's issued Ordinary Share capital.
|
Nexteq plc Jon Jayal, Chief Executive Officer Johan Olivier, Chief Financial Officer
|
Tel: +44 (0)1223 892 696 |
|
Nominated Adviser and Broker: Cavendish Capital Markets Ltd Matt Goode / Simon Hicks (Corporate Finance) Tim Redfern / Harriet Ward (ECM)
|
Tel: +44 (0) 20 7220 0500 |
|
Joint Broker: Canaccord Genuity Limited Simon Bridges / Andrew Potts
|
Tel: +44 (0) 20 7523 8000 |
|
Financial PR: Alma Strategic Communications Hilary Buchanan / Kieran Breheny |
Tel: +44 (0)20 3405 0205 |
About Nexteq
Nexteq (AIM: NXQ) is a strategic technology solutions provider to customers in selected industrial markets. Its innovative technology enables the manufacturers of global electronic equipment to outsource the design, development and supply of non-core aspects of their product offering. By outsourcing elements of their technology stack to Nexteq, customers can focus their product development effort on the most critical drivers of their business' success.
Our solutions are delivered through a global sales team and leverage the Group's electronic hardware, software, display and mechanical engineering expertise. Our Taiwan operation is at the heart of Asian supply networks and facilitates cost effective manufacturing and strategic supply chain management.
The Group operates in seven countries and services over 500 customers across 50 countries.
Nexteq operates two distinct brands: Quixant, a specialised computer platforms provider, and Densitron, leaders in human machine interface technology, each with dedicated sales, account management and product innovation teams. Founded in 2005, and later floating on the London Stock Exchange's AIM stock market as Quixant plc, the Group rebranded to Nexteq in 2023.
Further information on Nexteq and its divisions can be found at www.nexteqplc.com.
|
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
||||
|
a) |
|
Nick Jarmany |
|||
|
2 |
Reason for the notification
|
||||
|
a) |
Position/status |
Non-Executive Deputy Chair of the Group |
|||
|
b) |
Initial notification /Amendment |
Initial Notification |
|||
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
||||
|
a) |
Name |
Nexteq plc |
|||
|
b) |
LEI |
2138003VERSWQP561X71 |
|||
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||
|
a)
|
Description of the financial instrument, type of instrument |
Ordinary shares of 0.1 pence each |
|||
|
|
|
||||
|
Identification code |
GB00B99PCP71 |
||||
|
|
|
||||
|
b) |
Nature of the transaction |
Transfer of ordinary shares of 0.1p for nil consideration. |
|||
|
c) |
Price(s) and volume(s) |
|
|
|
|
|
|
|
Price(s) |
Volume(s) |
|
|
|
|
|
nil nil nil nil nil nil |
14,000 14,000 10,500 10,500 10,500 10,500 |
|
|
|
|
|
|
|
|
|
|
d) |
Aggregated information |
|
|||
|
- Aggregated volume |
70,000 Ordinary Shares
|
||||
|
|
|
||||
|
- Price |
nil |
||||
|
|
|
||||
|
e) |
Date of the transaction |
13 March 2024 |
|||
|
f) |
Place of the transaction |
London Stock Exchange |
|||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
